AMD Pulls Back as Borrow Costs Collapse — But Shorts Keep Building

AMD has drifted lower from last week's $516 peak to $504, even as the analyst consensus gap remains wide and borrowing costs have fallen sharply — a week where the bears are adding positions but paying almost nothing to do so.

The short interest picture has continued building despite the stock's retreat. Shorts grew roughly 6% over the past week to 42.1 million shares, representing 2.6% of free float — still a low absolute level, but the direction of travel is consistent: this is the third consecutive week of net short accumulation. The more striking development is what happened to the cost of that conviction. Borrow costs collapsed 36% on the week to just 0.21%, the lowest reading in the 30-day window by a wide margin after briefly spiking to 0.71% on September 11. Availability is effectively unlimited — the lending pool shows no meaningful constraints whatsoever. That combination tells a specific story: shorts are rebuilding positions, but they are doing so cheaply and without any friction from the borrow market. There is no squeeze pressure here. Options traders are equally measured — the put/call ratio of 1.14 is fractionally below its 20-day average of 1.15, producing a z-score near zero. Neither side of the options market is pressing a strong directional bet into next week.

The Street, by contrast, remains conspicuously one-directional. The mean analyst price target is $616.51, implying roughly 22% upside from current levels — a gap that has widened slightly as the stock gave back last week's gains. Of the 43 analysts covering AMD, the overwhelming majority carry buy-equivalent ratings. The most recent initiation came September 10 from Piper Sandler at Overweight with a $600 target, adding to a chorus that includes Raymond James at Strong Buy ($641), Wells Fargo Overweight ($700), and Rosenblatt at Buy ($700). Morgan Stanley and JP Morgan remain the outliers — both raised targets materially following Q2 results in early August, but both sit at neutral-equivalent ratings with targets of $465 and $550 respectively. The analyst recommendation differential factor ranks in the 99th percentile across the ORTEX universe, meaning the bullish alignment is about as lopsided as it gets. Valuation multiples have compressed modestly: the trailing P/E has eased about four turns over the past month to 37x, and EV/EBITDA has come in similarly. Neither suggests the stock is cheap, but the compression at least removes some of the premium froth.

The most notable insider activity this week was entirely mechanical rather than discretionary. CEO Lisa Su sold approximately $15.5 million in AMD shares across multiple tranches on September 10 — all executed under a pre-arranged 10b5-1 trading plan. Planned sales under 10b5-1 programmes are set up well in advance and carry little informational weight about near-term management conviction. The 90-day net insider position is -$78.4 million in value terms, but that figure reflects the same pre-planned cadence rather than a shift in sentiment. On the institutional side, JP Morgan Asset Management added 12.8 million shares as of September 1, and FMR (Fidelity) added 10.5 million — both meaningful additions from significant holders, suggesting that while CEO share sales continue on schedule, institutional buyers have been active on the other side.

AMD's closest correlated peers have had a notably rougher week. Lam Research fell 15.5% over the five sessions, MKS Instruments dropped 12.8%, Lattice Semiconductor shed 9.4%, and Micron lost 7.3%. Against that backdrop, AMD's near-flat week — down just 0.3% — looks considerably more resilient than the raw number suggests. The next earnings event is scheduled for November 3, and Q2 results in early August produced a muted post-print reaction of roughly -0.5% the following day and -2.1% over five days, against a backdrop of record revenue of $11.54 billion and strong data center guidance.

The setup heading into next week centres on whether the rebuilding short position — growing steadily but cheaply — becomes more aggressive as the stock continues to lag both the analyst consensus and its own year-to-date momentum, or whether the combination of institutional inflows, improving EPS momentum scores, and a peer group in deeper trouble draws buyers back toward that $616 mean target.